{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:55:07Z","timestamp":1786996507522,"version":"build-2736575974"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T00:00:00Z","timestamp":1598659200000},"content-version":"am","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.schres.2019.07.040","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T08:09:28Z","timestamp":1564646968000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Clinical determinants of fever in clozapine users and implications for treatment management: A narrative review"],"prefix":"10.1016","volume":"211","author":[{"given":"H\u00e9l\u00e8ne","family":"Verdoux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9lia","family":"Quiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7756-2314","authenticated-orcid":false,"given":"Jose","family":"de Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2019.07.040_bb0005","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1177\/0004867413502095","article-title":"Clozapine-induced pneumonitis","volume":"47","author":"Aldridge","year":"2013","journal-title":"Aust NZ J Psychiatr"},{"issue":"1","key":"10.1016\/j.schres.2019.07.040_bb0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/acps.12742","article-title":"International trends in clozapine use: a study in 17 countries","volume":"136","author":"Bachmann","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"issue":"3","key":"10.1016\/j.schres.2019.07.040_bb0015","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0920-9964(95)00047-X","article-title":"Myocarditis under therapy with clozapine","volume":"17","author":"Bandelow","year":"1995","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2019.07.040_bb0020","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijcard.2017.12.102","article-title":"A systematic review of clozapine-induced myocarditis","volume":"259","author":"Bellissima","year":"2018","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.schres.2019.07.040_bb0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40268-014-0078-0","article-title":"Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis","volume":"15","author":"Belvederi Murri","year":"2015","journal-title":"Drugs in R&D"},{"key":"10.1016\/j.schres.2019.07.040_bb0030","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1192\/bjp.173.5.440b","article-title":"Clozapine-induced extrinsic allergic alveolitis","volume":"173","author":"Benning","year":"1998","journal-title":"Br. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2019.07.040_bb0035","first-page":"547","article-title":"Acute generalized exanthematic pustulosis following administration of clozapine (Leponex(R)). First case","volume":"124","author":"Bosonnet","year":"1997","journal-title":"Annales Dermatologie Venereologie"},{"issue":"4","key":"10.1016\/j.schres.2019.07.040_bb0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/WNF.0000000000000088","article-title":"Clozapine and fever: a case of continued therapy with clozapine","volume":"38","author":"Bruno","year":"2015","journal-title":"Clin. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.schres.2019.07.040_bb0045","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1177\/0004867415590629","article-title":"Fever and elevated CRP-related to clozapine dose","volume":"50","author":"Buist","year":"2016","journal-title":"Aust NZ J Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2019.07.040_bb0050","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/JCP.0000000000000550","article-title":"Life-threatening lupus-like syndrome associated with clozapine","volume":"36","author":"Buzina","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.schres.2019.07.040_bb0055","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1176\/appi.ps.201500493","article-title":"An initiative to improve clozapine prescribing in New York state","volume":"67","author":"Carruthers","year":"2016","journal-title":"Psychiatr. Serv."},{"issue":"1","key":"10.1016\/j.schres.2019.07.040_bb0060","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/0091217415621269","article-title":"Clozapine-induced myocarditis may be associated with rapid titration: a case report verified with autopsy","volume":"51","author":"Chopra","year":"2016","journal-title":"Int J Psychiatr Med"},{"issue":"12","key":"10.1016\/j.schres.2019.07.040_bb0065","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1177\/070674370805301211","article-title":"The incidence and characteristics of clozapine-induced fever in a local psychiatric unit in Hong Kong","volume":"53","author":"Chung","year":"2008","journal-title":"Can. J. Psychiatr."},{"issue":"3","key":"10.1016\/j.schres.2019.07.040_bb0070","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/17512433.2019.1577134","article-title":"A comprehensive review of swallowing difficulties and dysphagia associated with antipsychotics in adults","volume":"12","author":"Cicala","year":"2019","journal-title":"Exp Rev Clin Pharmacol"},{"key":"10.1016\/j.schres.2019.07.040_bb0075","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.schres.2017.03.045","article-title":"Elevated clozapine levels associated with infection: a systematic review","volume":"192","author":"Clark","year":"2018","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2019.07.040_bb0080","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/acps.12294","article-title":"Prescribers fear as a major side-effect of clozapine","volume":"130","author":"Cohen","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"issue":"12","key":"10.1016\/j.schres.2019.07.040_bb0085","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s40263-017-0481-5","article-title":"Clozapine and gastrointestinal hypomotility","volume":"31","author":"Cohen","year":"2017","journal-title":"CNS Drugs"},{"issue":"7","key":"10.1016\/j.schres.2019.07.040_bb0090","doi-asserted-by":"crossref","first-page":"959","DOI":"10.4088\/JCP.09l05692yel","article-title":"Clozapine rechallenge following clozapine-induced pericarditis","volume":"71","author":"Crews","year":"2010","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2019.07.040_bb0095","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1192\/bjpo.bp.116.003228","article-title":"Inflammatory response to clozapine in the absence of myocarditis: case report","volume":"2","author":"Davey","year":"2016","journal-title":"Br J Psychiatry Open"},{"issue":"1","key":"10.1016\/j.schres.2019.07.040_bb0100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/acps.12233","article-title":"Discontinuation of clozapine: a 15-year naturalistic retrospective study of 320 patients","volume":"130","author":"Davis","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"issue":"4","key":"10.1016\/j.schres.2019.07.040_bb0105","doi-asserted-by":"crossref","first-page":"505","DOI":"10.9758\/cpn.2018.16.4.505","article-title":"Clozapine-related sudden pericarditis in a patient taking long acting aripiprazole and valproate: a case report","volume":"16","author":"De Berardis","year":"2018","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"6","key":"10.1016\/j.schres.2019.07.040_bb0110","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0278-5846(03)00148-9","article-title":"Serious respiratory infections can increase clozapine levels and contribute to side effects: a case report","volume":"27","author":"de Leon","year":"2003","journal-title":"Progress Neuro-psychopharmacol & Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2019.07.040_bb0115","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1176\/appi.ajp.2013.13070866","article-title":"Management of clozapine-induced fever in a child","volume":"171","author":"Driver","year":"2014","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2019.07.040_bb0120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00004714-199304000-00013","article-title":"Transient fever and hematologic abnormalities during clozapine use","volume":"13","author":"Druss","year":"1993","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.schres.2019.07.040_bb0125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/10401239509149034","article-title":"Clozapine-caused eosinophilic colitis","volume":"7","author":"Friedberg","year":"1995","journal-title":"Ann. Clin. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2019.07.040_bb0130","first-page":"27","article-title":"Clozapine-induced eosinophilic colitis","volume":"12","author":"Ginsberg","year":"2005","journal-title":"Primary Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2019.07.040_bb0135","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/JCP.0000000000000256","article-title":"Simple pulmonary eosinophilia associated with clozapine treatment","volume":"35","author":"Hashimoto","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.schres.2019.07.040_bb0140","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1590\/2237-6089-2015-0066","article-title":"Heat stroke during long-term clozapine treatment: should we be concerned about hot weather?","volume":"38","author":"Hoffmann","year":"2016","journal-title":"Trends Psychiatr Psychother"},{"issue":"1","key":"10.1016\/j.schres.2019.07.040_bb0145","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4088\/JCP.14m09301","article-title":"Antipsychotic reexposure and recurrent pneumonia in schizophrenia: a nested case-control study","volume":"77","author":"Hung","year":"2016","journal-title":"J Clin Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.schres.2019.07.040_bb0150","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0920-9964(01)00262-6","article-title":"The characteristics of clozapine-induced fever","volume":"56","author":"Jeong","year":"2002","journal-title":"Schizophr. Res."},{"issue":"7","key":"10.1016\/j.schres.2019.07.040_bb0155","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1176\/appi.ajp.162.7.1386-a","article-title":"Clozapine-induced eosinophilic colitis","volume":"162","author":"Karmacharya","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2019.07.040_bb0160","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881104040250","article-title":"Heat stroke in schizophrenia during clozapine treatment: rapid recognition and management","volume":"18","author":"Kerwin","year":"2004","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.schres.2019.07.040_bb0165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.schres.2018.03.006","article-title":"Clozapine-induced cardiomyopathy and myocarditis monitoring: a systematic review","volume":"199","author":"Knoph","year":"2018","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2019.07.040_bb0170","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1345\/aph.1L467","article-title":"Increases in C-reactive protein may predict recurrence of clozapine-induced fever","volume":"43","author":"Kohen","year":"2009","journal-title":"Ann. Pharmacother."},{"issue":"3","key":"10.1016\/j.schres.2019.07.040_bb0175","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/schbul\/sbr202","article-title":"Second-generation antipsychotic medications and risk of pneumonia in schizophrenia","volume":"39","author":"Kuo","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.schres.2019.07.040_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.genhosppsych.2012.03.002","article-title":"Pityriasis rosea-like eruption associated with clozapine: a case report","volume":"34","author":"Lai","year":"2012","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2019.07.040_bb0185","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/JCP.0000000000000922","article-title":"Hepatitis, interstitial nephritis, and pancreatitis in association with clozapine treatment: a systematic review of case series and reports","volume":"38","author":"Lally","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.schres.2019.07.040_bb0190","first-page":"297","article-title":"Increased use of antibiotics in clozapine-treated patients","volume":"18","author":"Landry","year":"2003","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"1\u20133","key":"10.1016\/j.schres.2019.07.040_bb0195","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.schres.2016.05.002","article-title":"Reasons for discontinuing clozapine: a cohort study of patients commencing treatment","volume":"174","author":"Legge","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2019.07.040_bb0200","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1749-7922-2-21","article-title":"Necrotising colitis related to clozapine? A rare but life threatening side effect","volume":"2","author":"Leong","year":"2007","journal-title":"World J Emerg Surg"},{"issue":"10","key":"10.1016\/j.schres.2019.07.040_bb0205","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1345\/aph.1K126","article-title":"Characterization and clinical management of clozapine-induced fever","volume":"41","author":"Lowe","year":"2007","journal-title":"Ann. Pharmacother."},{"issue":"12","key":"10.1016\/j.schres.2019.07.040_bb0210","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/pds.1476","article-title":"Clozapine-related agranulocytosis associated with fever of unknown origin, protective hospitalisation, and multiple adverse events related to the administration of empiric antimicrobial treatment","volume":"16","author":"Manfredi","year":"2007","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"1","key":"10.1016\/j.schres.2019.07.040_bb0215","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s13104-017-2662-1","article-title":"Multiorgan eosinophilic infiltration after initiation of clozapine therapy: a case report","volume":"10","author":"Marchel","year":"2017","journal-title":"BMC Res Notes"},{"issue":"4","key":"10.1016\/j.schres.2019.07.040_bb0220","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1503\/jpn.120206","article-title":"Management of clozapine-induced fever: a case of continued therapy throughout fever","volume":"38","author":"Martin","year":"2013","journal-title":"JPN"},{"issue":"7","key":"10.1016\/j.schres.2019.07.040_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"issue":"4","key":"10.1016\/j.schres.2019.07.040_bb0230","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/WNF.0b013e318197a2f2","article-title":"Clozapine-induced serositis: review of its clinical features, pathophysiology and management strategies","volume":"32","author":"Mouaffak","year":"2009","journal-title":"Clin. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.schres.2019.07.040_bb0235","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/acps.12898","article-title":"Meta-analysis examining the epidemiology of clozapine-associated neutropenia","volume":"138","author":"Myles","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2019.07.040_bb5000","author":"Netherlands Clozapine Collaboration Group"},{"issue":"7","key":"10.1016\/j.schres.2019.07.040_bb0240","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.euroneuro.2009.03.002","article-title":"Increased use of antibiotics in patients treated with clozapine","volume":"19","author":"Nielsen","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"7","key":"10.1016\/j.schres.2019.07.040_bb0245","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1177\/0269881108100320","article-title":"Psychiatrists' attitude towards and knowledge of clozapine treatment","volume":"24","author":"Nielsen","year":"2010","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.schres.2019.07.040_bb0250","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1600-0447.2011.01710.x","article-title":"Optimizing clozapine treatment","volume":"123","author":"Nielsen","year":"2011","journal-title":"Acta Psychiatr. Scand."},{"issue":"6","key":"10.1016\/j.schres.2019.07.040_bb0255","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4088\/JCP.12r08064","article-title":"Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided?","volume":"74","author":"Nielsen","year":"2013","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2019.07.040_bb0260","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s40263-016-0311-1","article-title":"Worldwide differences in regulations of clozapine use","volume":"30","author":"Nielsen","year":"2016","journal-title":"CNS drugs"},{"issue":"8","key":"10.1016\/j.schres.2019.07.040_bb0265","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/pds.3804","article-title":"Antipsychotic drug exposure and risk of pneumonia: a systematic review and meta-analysis of observational studies","volume":"24","author":"Nose","year":"2015","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"1","key":"10.1016\/j.schres.2019.07.040_bb0270","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-0447.2011.01776.x","article-title":"Reason for clozapine cessation","volume":"125","author":"Pai","year":"2012","journal-title":"Acta Psychiatr. Scand."},{"issue":"7","key":"10.1016\/j.schres.2019.07.040_bb0275","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1176\/ajp.150.7.1126a","article-title":"Spiking fever and profuse diarrhea with clozapine treatment","volume":"150","author":"Patterson","year":"1993","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2019.07.040_bb0280","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/jcp.0b013e31815a257f","article-title":"Clozapine-induced microscopic colitis: a case report and review of the literature","volume":"27","author":"Pelizza","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2019.07.040_bb0285","first-page":"1","article-title":"Clozapine is associated with secondary antibody deficiency","author":"Ponsford","year":"2018","journal-title":"Brit J Psychiatr"},{"key":"10.1016\/j.schres.2019.07.040_bb0290","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1186\/s13104-015-1777-5","article-title":"Clozapine induced pancytopenia leading to severe sepsis: an unusual early complication","volume":"8","author":"Pushpakumara","year":"2015","journal-title":"BMC Research Notes"},{"issue":"3","key":"10.1016\/j.schres.2019.07.040_bb0295","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/1574886309666140428115040","article-title":"Clozapine safety, 40 years later","volume":"9","author":"Raja","year":"2014","journal-title":"Curr. Drug Saf."},{"issue":"5","key":"10.1016\/j.schres.2019.07.040_bb0300","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1345\/aph.1G552","article-title":"Clozapine-induced systemic lupus erythematosus","volume":"40","author":"Rami","year":"2006","journal-title":"Ann. Pharmacother."},{"issue":"1\u20133","key":"10.1016\/j.schres.2019.07.040_bb0305","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.schres.2012.06.020","article-title":"Immunomodulatory effects of clozapine and their clinical implications: what have we learned so far?","volume":"140","author":"Roge","year":"2012","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2019.07.040_bb0310","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/acps.12827","article-title":"Adverse cardiac events in out-patients initiating clozapine treatment: a nationwide register-based study","volume":"137","author":"Rohde","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"issue":"8","key":"10.1016\/j.schres.2019.07.040_bb0315","doi-asserted-by":"crossref","first-page":"976","DOI":"10.4088\/JCP.09m05024yel","article-title":"Diagnostic characteristics of clozapine-induced myocarditis identified by an analysis of 38 cases and 47 controls","volume":"71","author":"Ronaldson","year":"2010","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2019.07.040_bb0320","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/acps.12416","article-title":"Clozapine-induced myocarditis, a widely overlooked adverse reaction","volume":"132","author":"Ronaldson","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"issue":"2","key":"10.1016\/j.schres.2019.07.040_bb0325","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.psym.2018.07.009","article-title":"Thirty years of both ignorance and clinical experience suggest that clozapine intoxication during co-occurring infections and inflammation may have higher morbidity and mortality than is currently believed","volume":"60","author":"Ruan","year":"2019","journal-title":"Psychosomatics"},{"issue":"6","key":"10.1016\/j.schres.2019.07.040_bb0330","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.psym.2017.05.003","article-title":"Pneumonia can cause clozapine intoxication: a case report","volume":"58","author":"Ruan","year":"2017","journal-title":"Psychosomatics"},{"issue":"2","key":"10.1016\/j.schres.2019.07.040_bb0335","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/JCP.0000000000001018","article-title":"Clozapine metabolism in East Asians and Caucasians: a pilot exploration of the prevalence of poor metabolizers and a systematic review","volume":"39","author":"Ruan","year":"2019","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.schres.2019.07.040_bb0340","doi-asserted-by":"crossref","first-page":"e434","DOI":"10.1097\/MJT.0000000000000806","article-title":"Clozapine-associated pulmonary embolism: a high-mortality, dose-independent and early-onset adverse effect","volume":"25","author":"Sarvaiya","year":"2018","journal-title":"Am. J. Ther."},{"issue":"3","key":"10.1016\/j.schres.2019.07.040_bb0345","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/JCP.0000000000000124","article-title":"Pulmonary embolism and aspiration pneumonia after reexposure to clozapine: pulmonary adverse effects of clozapine","volume":"34","author":"Schmidinger","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.schres.2019.07.040_bb0350","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/YIC.0000000000000162","article-title":"Clozapine usage increases the incidence of pneumonia compared with risperidone and the general population: a retrospective comparison of clozapine, risperidone, and the general population in a single hospital over 25 months","volume":"32","author":"Stoecker","year":"2017","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.schres.2019.07.040_bb0355","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/wps.20567","article-title":"Management of common adverse effects of antipsychotic medications","volume":"17","author":"Stroup","year":"2018","journal-title":"World Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2019.07.040_bb0360","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.genhosppsych.2013.03.022","article-title":"Clozapine-induced elevated C-reactive protein and fever mimic infection","volume":"35","author":"Stuhec","year":"2013","journal-title":"Gen Hosp Psychiatr"},{"issue":"2","key":"10.1016\/j.schres.2019.07.040_bb0365","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1192\/bjp.bp.108.051979","article-title":"Reasons for discontinuing clozapine: matched, case-control comparison with risperidone long-acting injection","volume":"194","author":"Taylor","year":"2009","journal-title":"Br. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.schres.2019.07.040_bb0370","doi-asserted-by":"crossref","first-page":"880","DOI":"10.4088\/JCP.v63n1005","article-title":"Clozapine-induced fevers and 1-year clozapine discontinuation rate","volume":"63","author":"Tham","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2019.07.040_bb0375","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2648.2005.03520.x","article-title":"Fever: a concept analysis","volume":"51","author":"Thompson","year":"2005","journal-title":"J. Adv. Nurs."},{"issue":"2","key":"10.1016\/j.schres.2019.07.040_bb0380","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00002826-199704000-00009","article-title":"Spiking fevers with clozapine treatment","volume":"20","author":"Tremeau","year":"1997","journal-title":"Clin. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.schres.2019.07.040_bb0385","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1192\/bjp.bp.111.105189","article-title":"Comparison of neuroleptic malignant syndrome induced by first- and second-generation antipsychotics","volume":"201","author":"Trollor","year":"2012","journal-title":"Br. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2019.07.040_bb0390","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/acps.12344","article-title":"Clozapine use pattern in persons with and without treatment for Parkinson's disease in real-world conditions: a naturalistic study in a community-based sample","volume":"130","author":"Verdoux","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"issue":"6","key":"10.1016\/j.schres.2019.07.040_bb0395","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/acps.12554","article-title":"Geographical disparities in prescription practices of lithium and clozapine: a community-based study","volume":"133","author":"Verdoux","year":"2016","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2019.07.040_bb0400","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.schres.2018.05.046","article-title":"Prescriber and institutional barriers and facilitators of clozapine use: a systematic review","volume":"201","author":"Verdoux","year":"2018","journal-title":"Schizophr. Res."},{"issue":"830","key":"10.1016\/j.schres.2019.07.040_bb0405","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/pgmj.70.830.940-a","article-title":"Acute severe adverse clozapine reaction resembling systemic lupus erythematosus","volume":"70","author":"Wickert","year":"1994","journal-title":"Postgrad. Med. J."},{"issue":"2","key":"10.1016\/j.schres.2019.07.040_bb0410","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/01.jcp.0000117430.83724.f9","article-title":"Clozapine-induced lupus erythematosus","volume":"24","author":"Wolf","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2019.07.040_bb0415","first-page":"1039","article-title":"The severe complication of Stevens-Johnson syndrome induced by long-term clozapine treatment in a male schizophrenia patient: a case report","volume":"11","author":"Wu","year":"2015","journal-title":"Neuropsychiat Dis Treat"},{"issue":"1","key":"10.1016\/j.schres.2019.07.040_bb0420","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.4088\/JCP.12m07938","article-title":"Antipsychotic drugs, mood stabilizers, and risk of pneumonia in bipolar disorder: a nationwide case-control study","volume":"74","author":"Yang","year":"2013","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2019.07.040_bb0425","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1177\/070674370304800519","article-title":"Clozapine-induced aplastic anemia in a patient with Parkinson's disease","volume":"48","author":"Ziegenbein","year":"2003","journal-title":"Can. J. Psychiatr."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996419303202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996419303202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:29:16Z","timestamp":1760297356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996419303202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":86,"alternative-id":["S0920996419303202"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2019.07.040","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical determinants of fever in clozapine users and implications for treatment management: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2019.07.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}